Member Contact: Laura Issa
Position: Business Development Search & Evaluation Lead, ANZ
Industry: Biotech & Pharmaceuticals
AbbVie Inc is a global, research and development-based biopharmaceutical company committed to developing innovative, advanced therapies for some of the world's most complex, difficult-to-treat and critical conditions. AbbVie’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across primary therapeutic areas: immunology, oncology, virology, women’s health and neuroscience. Founded in 2013, following a separation from Abbott Laboratories (established in 1888), AbbVie has the tradition, rigor and robustness of a big pharma company coupled with the entrepreneurship and nimbleness of a small biotech. AbbVie’s 30,000 scientists and employees are dedicated to the discovery science, translational research, clinical development and commercialisation of transformative, specialty care biopharmaceuticals, spending over $5 billion per year on R&D. Today, AbbVie operates in more than 175 countries and our products treat greater than 32 conditions.